Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2005-04-26
2005-04-26
Tate, Christopher R. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S012200, C530S350000, C530S361000, C424S094100, C424S094600, C435S183000, C435S195000
Reexamination Certificate
active
06884771
ABSTRACT:
The present invention relates to the discovery of novel genes encoding an angiotensin converting enzyme, Angiotensin Converting Enzyme-2 (ACE-2). The invention provides therapeutics, prognostic and diagnostics methods for treating blood pressure related disorders as well as various types of allergic conditions, among others. Also disclosed are screening assays for identifying compounds for treating and preventing these conditions.
REFERENCES:
patent: 0 974 664 (2000-01-01), None
patent: WO 0018899 A2 (2000-04-01), None
DGENE Accession No. AAY 84562 for “A human angiotensin converting enzyme-2 (ACE-2) protein,” Jul. 25, 2000.
DGENE Accession No. AAA12764 for “cDNA encoding a human angiotensin converting enzyme-2 (ACE-2),” Jul. 25, 2000.
DGENE Accession No. AAY67310 for “Human MPROT15 amino acid sequence #1,” Apr. 11, 2000.
DGENE Accession No. AAZ59465 for “Human MPROT15 coding sequence #1,” Apr. 11, 2000.
EMBL Accession No. AF241254 for “Homo sapiensangiotensin converting enzyme-like protein mRNA, complete cds,” Jul. 1, 2000.
SWALL Accession No. Q9NRA7 for “Angiotensin converting enzyme-like protein (ACE-related carboxypeptidase ACE2)”, Oct. 1, 2000.
Bernstein, K. E. “Two ACEs and a heart,”NatureJun. 20, 2002; 417:799,801-802.
Donoghue, M. et al. “A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9,”Circulation ResearchSep. 1, 2000; 87(5):e1-e9.
Tipnis, S.R. et al. “A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase,”Journal of Biological ChemistryOct. 27, 2000; 275(43):33238-33243.
Acton Susan
Hsieh Frank Y.
Robison Keith E.
Chism B. Dell
Millennium Pharmaceuticals Inc.
Tate Christopher R.
LandOfFree
Angiotensin converting enzyme homolog and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Angiotensin converting enzyme homolog and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Angiotensin converting enzyme homolog and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3373772